IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
18 hedge funds and large institutions have $7.02M invested in Interpace Biosciences, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.19M | |
| 2 | +$983K | |
| 3 | +$465K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$194K |
| 5 |
VF
Virtu Financial
New York
|
+$116K |
Top Sellers
| 1 | -$830K | |
| 2 | -$23K | |
| 3 | -$14K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$12K |
| 5 |
BA
Ballew Advisors
Jackson,
Mississippi
|
-$11K |